Kerala Ayurveda Limited (BOM:530163)
181.50
+8.60 (4.97%)
At close: Sep 4, 2026
Kerala Ayurveda Revenue
Kerala Ayurveda had revenue of 331.93M INR in the quarter ending June 30, 2026, with 16.01% growth. This brings the company's revenue in the last twelve months to 1.36B, up 10.09% year-over-year. In the fiscal year ending March 31, 2026, Kerala Ayurveda had annual revenue of 1.31B with 8.99% growth.
Revenue (ttm)
1.36B
Revenue Growth
+10.09%
P/S Ratio
1.70
Revenue / Employee
3.70M
Employees
367
Market Cap
2.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 108.12M | 8.99% |
| Mar 31, 2025 | 1.20B | 171.82M | 16.66% |
| Mar 31, 2024 | 1.03B | 95.28M | 10.18% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 997.10M |
| Coral Laboratories | 967.01M |